相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Association Between AURKA Gene rs2273535 Polymorphism and Gastric Cancer Risk in a Chinese Population
Xiaoyan Zhou et al.
FRONTIERS IN PHYSIOLOGY (2018)
Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy
Yuqian Liao et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Ki-67 evaluation in breast cancer: The daily diagnostic practice
Lukasz Fulawka et al.
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY (2017)
AURKA promotes cancer metastasis by regulating epithelial-mesenchymal transition and cancer stem cell properties in hepatocellular carcinoma
Chenlin Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women
Lotte E. Elshof et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Selection and evolution in the genomic landscape of copy number alterations in ductal carcinoma in situ (DCIS) and its progression to invasive carcinoma of ductal/no special type: a meta-analysis
Swapnil Ulhas Rane et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Aurora kinase A gene copy number is associated with the malignant transformation of colorectal adenomas but not with the serrated neoplasia progression
Laura Casorzo et al.
HUMAN PATHOLOGY (2015)
Co-Expression of p16, Ki67 and COX-2 Is Associated with Basal Phenotype in High-Grade Ductal Carcinoma In Situ of the Breast
Amanda Arantes Perez et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2015)
Correlation of histopathologic features of ductal carcinoma in situ of the breast with the oncotype DX DCIS score
Adriana Knopfelmacher et al.
MODERN PATHOLOGY (2015)
Ductal Carcinoma In Situ of the Breast: Can Biomarkers Improve Current Management?
John M. S. Bartlett et al.
CLINICAL CHEMISTRY (2014)
COX-2, p16 and Ki67 expression in DCIS, microinvasive and early invasive breast carcinoma with extensive intraductal component
M. Bartova et al.
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY (2014)
Prediction of Oncotype DX and TAILORx risk categories using histopathological and immunohistochemical markers by classification and regression tree (CART) analysis
Helen Ingoldsby et al.
BREAST (2013)
Mechanisms Governing Metastatic Dormancy and Reactivation
Filippo G. Giancotti
CELL (2013)
Aurora A kinase (AURKA) in normal and pathological cell division
Anna S. Nikonova et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Emerging landscape of oncogenic signatures across human cancers
Giovanni Ciriello et al.
NATURE GENETICS (2013)
Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2011)
Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study
Cathy B. Moelans et al.
CELLULAR ONCOLOGY (2011)
Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review
Sara A. Lari et al.
JOURNAL OF CANCER (2011)
Molecular profiling of invasive breast cancer by multiplex ligation-dependent probe amplification-based copy number analysis of tumor suppressor and oncogenes
Cathy B. Moelans et al.
MODERN PATHOLOGY (2010)
Quantitative in situ analysis of β-catenin expression in breast cancer shows decreased expression is associated with poor outcome
Marisa Dolled-Filhart et al.
CANCER RESEARCH (2006)
X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
RL Camp et al.
CLINICAL CANCER RESEARCH (2004)
Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery
GP Boland et al.
BRITISH JOURNAL OF SURGERY (2003)
分享论文
